Documentos de Académico
Documentos de Profesional
Documentos de Cultura
4863-Article Text-17768-1-10-20130429 PDF
4863-Article Text-17768-1-10-20130429 PDF
UNIVERSITAS 2007
SCIENTIARUM
Revista de la Facultad de Ciencias
Vol. 12 N° 2, 5-22
1
Grupo de Inmunobiología y Biología Celular. Facultad de Ciencias, Pontificia Universidad
Javeriana. Carrera 7 # 43-82. Bogotá, Colombia
2
Proteomics Laboratory. System Health Science Center College of Medicine.
Scott & White Memorial Hospital and Clinic and The Texas A&M University, USA
susana.fiorentino@javeriana.edu.co
Resumen
Las proteínas de choque térmico (HSPs), particularmente la proteína inducible Hsp72, tienen un papel
importante en el favorecimiento de una respuesta antitumoral, transportando péptidos inmunogénicos o
actuando como inmunoestimulantes, induciendo la activación y maduración de células dendríticas (DC).
La función básica de estas proteínas, como chaperonas moleculares dependientes de ATP, incrementa la
sobrevivencia celular bajo cualquier tipo de estrés. La función chaperona es natural para la estructura de
las proteínas de la familia Hsp70, las cuales tienen un dominio C-terminal que une proteínas no-plegadas
y péptidos y adicionalmente tiene un N-terminal con atividad ATPasa que controla la apertura y cierre del
surco de unión al péptido. Su papel inmunoestimulante podría antagonizar con su actividad protectora
contra la muerte celular inducida por estrés o agentes citotóxicos. La Hsp70 inducible está implicada en
llevar a cabo estas dos funciones, los cuales son el propósito de esta revisión. Además, es posible que otros
miembros de la familia Hsp70 estén implicados, pero en diferentes formas: induciendo respuesta inmune
o como promotores del crecimiento tumoral inhibiendo la apoptosis. La comprensión de los mecanismos
que regulan las dos actividades, es crucial en el desarrollo de una terapia efectiva antitumoral a través de
la búsqueda de sustancias que, preservando su potencial inmunogénico, no incrementen la resistencia del
tumor a la terapia antitumoral clásica.
Palabras clave: proteínas de choque térmico, cáncer, a poptosis, respuesta inmune antitumoral.
Abstract
Heat shock proteins (HSP), particularly inducible HSP72 protein, have an important role generating an
effective antitumoral response as immunogenic peptide carriers or as immunostimulants, when induce
activation and maturation of dendritic cells (DC). These proteins, as molecular chaperones ATP dependant,
increase cell survival under any kind of stress. Chaperone function is intrinsic of protein family HSP70
structure, having a C-terminal domain that binds unfolded proteins and peptides and a N-terminal ATPase
domain that controls peptide binding pocket opening and closing. Their immunostimulant role may
antagonize with their protective activity against cell death induced by stress or cytotoxic agents. Inducible
HSP70 protein is involved in carrying out these two functions, which is the purpose of this review.
Furthermore, other members of HSP70 protein family could be implicated, but in different ways: inducing
immune response or promoting tumoral growth inhibiting apoptosis. Comprehension of mechanisms that
regulate both activities is crucial in developing an effective antitumoral therapy through searching
substances, which preserving their immunogenic potential, do not increase tumor resistance to classical
antitumoral therapy.
Key words: antitumoral therapy, apoptosis, cancer, exosomes, heat shock proteins, immunostimulation.
5
Universitas Scientiarum, Vol. 12 N° 2, 5-22
6
Julio-diciembre 2007
7
Universitas Scientiarum, Vol. 12 N° 2, 5-22
8
Julio-diciembre 2007
9
Universitas Scientiarum, Vol. 12 N° 2, 5-22
10
Julio-diciembre 2007
11
Universitas Scientiarum, Vol. 12 N° 2, 5-22
12
Julio-diciembre 2007
hecho un trabajo reciente muestra que la ANDRE, F., SCHARTZ, N.E., CHAPUT, N.,
HSP70-2, una proteína esencial en la FLAMENT, C., RAPOSO, G., AMIG-
espermaogénesis, es un regulador impor- ORENA, S., ANGEVIN, E., ZITVOGEL,
tante del crecimiento tumoral (Rohde et L. Tumor-derived exosomes: a new
al., 2005; Daugaard et al., 2005), pero su source of tumor rejection antigens.
papel como inmunoestimulante aún no ha Vaccine 20 Suppl. 4: 2002a, A28-31.
sido estudiado.
ANDRE, F., SCHARTZ, N.E.,
MOVASSAGH, M., FLAMENT, C.,
CONCLUSIONES Y PERSPECTIVAS PAUTIER, P., MORICE, P., POMEL, C.,
LHOMME, C., ESCUDIER, B., L.E.
En resumen, la HSP70 soluble puede tener CHEVALIER, T., TURSZ, T.,
funciones inmunomoduladoras, activando AMIGORENA, S., RAPOSO, G.,
la respuesta inmune a través de las DC, sir- ANGEVIN, E., ZITVOGEL, L. Malig-
viendo como señal de peligro, y en los nant effusions and immunogenic tu-
exosomas, transportando antígenos tumo- mour-derived exosomes. Lancet,
rales o antígenos para la sensibilización 2002b, 360, 295-305.
cruzada. Por otra parte, la HSP70 intrace-
lular, actúa como factor protector aumen- ASEA, A., KRAEFT, S.K., KURT-JONES, E.A.,
tando la sobrevida de las células STEVENSON, M.A., CHEN, L.B.,
tumorales. Estas funciones aparentemente FINBERG, R.W., KOO, G.C.,
excluyentes, podrían estar estrechamente CALDERWOOD, S.K. HSP70 stimulates
ligadas y ocurrir espontáneamente in vivo. cytokine production through a CD14-
Sin embargo, es necesario definir claramen- dependant pathway, demonstrating its
te, tanto el papel de cada uno de los miem- dual role as a chaperone and cytokine.
bros de la familia de las HSP así como la Nature medicine, 2000, 6, 435-42.
temporalidad de sus funciones. La búsque-
da de nuevos agentes antitumorales, impli- ASEA, A., REHLI, M., KABINGU, E.,
ca en la actualidad, no solo el análisis de BOCH, J.A., BARE, O., AURON, P.E.,
los compuestos capaces de inducir STEVENSON, M.A., CALDERWOOD,
apoptosis de las células tumorales, sino S.K. Novel signal transduction path-
también de aquellos capaces de regular la way utilized by extracellular HSP70:
síntesis o la movilización de la HSP70 así role of toll-like receptor (TLR) 2 and
como los mecanismos que regulan las acti- TLR4. Journal of Biological Chemis-
vidades antiapoptóticas e inmunoestimu- try, 2002, 277,15028-34.
lantes. El conocimiento y la regulación de
BARRETO, A; GONZÁLEZ, J.M.,
estas actividades, por nuevos compuestos
KABINGU, E., ASEA, A., FIOREN-
dentro de los cuales se encuentran los pro-
TINO, S. Stress-induced release of
ductos naturales, son en la actualidad el
HSC70 from human tumors. Cellular
objeto principal de trabajo de nuestro la-
Immunology, 2003, 222, 97-104.
boratorio.
BASLER, M., YOUHNOVSKI, N., VAN DEN
LITERATURA CITADA BROEK, M., PRZYBYLSKI, M.,
GROETTRUP, M. Immunoproteasomes
ALTIERI, S.L., KHAN, A.N., TOMASI, T.B. down-regulate presentation of a sub-
Exosomes from plasmacytoma cells as dominant T cell epitope from lympho-
a tumor vaccine. Journal of Immuno- cytic choriomeningitis virus. Journal
therapy, 2004, 27, 282-8. of Immunology, 2004, 173, 3925-34.
13
Universitas Scientiarum, Vol. 12 N° 2, 5-22
BASU, S., BINDER, R.J., SUTO, R., fects and biological outcomes. Jour-
ANDERSON, K.M., SRIVASTAVA, P.K. nal of Biological Chemistry, 2003,
Necrotic but not apoptotic cell death 278, 29571-80.
releases heat shock proteins; which
deliver a partial maturation signal to BINDER, R.J., KARIMEDDINI, D.,
dendritic cells and activate the NF- SRIVASTAVA, P.K. Adjuvanticity of
kappa B pathway. International Immu- alpha 2-macroglobulin; an indepen-
nology, 2000, 12, 1539-46. dent ligand for the heat shock protein
receptor CD91. Journal of Immunol-
BASU, S., BINDER, R.J., RAMALINGAM, ogy, 2001, 166, 4968-72.
T., SRIVASTAVA, P.K. CD91 is a com-
mon receptor for heat shock proteins BLACHERE, N.E., LI, Z., CHAN-
gp96; hsp90; hsp70; and calreticulin. DAWARKAR, R.Y., SUTO, R.,
Immunity, 2001, 14, 303-13. JAIKARIA, N.S., BASU, S., UDONO, H.,
SRIVASTAVA, P.K. Heat shock protein-
BAUSERO, M.A., GASTPAR, R., peptide complexes; reconstituted in
MULTHOFF, G., ASEA, A. Alternative vitro; elicit peptide-specific cytotoxic
mechanism by which IFN-gamma en- T lymphocyte response and tumor im-
hances tumor recognition: active re- munity. Journal of Experimental Medi-
lease of heat shock protein 72. Journal cine, 1997, 186, 1315-22.
of Immunology, 2005, 175, 2900-12.
BOUILLET, P. and STRASSER, A. BH3-
BEERE, H.M., WOLF, B.B., CAIN, K., only proteins – evolutionarily con-
KUWANA, T., TAILOR, P., served pro-apoptotic Bcl-2 family
MORIMOTO, R. I., COHEN, G. and members essential for initiating pro-
GREEN, D.R. Heat-shock protein 70 grammed cell death. Journal of Cellu-
inhibits apoptosis by preventing re- lar Science, 2002, 1567-74.
cruitment of procaspase-9 to the apaf-
1 apoptosome. Nature. Cellular BROQUET, A.H., THOMAS, G., MASLIAH,
Biology, 2000, 2, 469-75. J., TRUGNAN, G., BACHELET, M.
Expression of the molecular chaperone
BEERE, H.M. “The stress of dying”: the Hsp70 in detergent-resistant micro-
role of heat shock proteins in the regu- domains correlates with its membrane
lation of apoptosis. Journal of Cellu- delivery and release. Journal of Bio-
lar Science, 2004, 117(Pt 13), 2641-51. logical Chemistry, 2003, 278, 21601-
6.
BEERE, H.M. Death versus survival: func-
tional interaction between the BUTTIGLIERI, S., GALETTO, A., FORNO,
apoptotic and stress-inducible heat S., DE ANDREA, M., MATELA, L. In-
shock protein pathways. Journal of fluence of drug-induced apoptotic
Clinical Investigation, 2005, 115, death on processing and presentation
2633-9. of tumor antigens by dendritic cells.
International Journal of Cancer, 2003,
BELMOKHTAR, C.A., HILLION, J; 106, 516-20.
DUDOGNON, C., FIORENTINO, S.,
FLEXOR, M., LANOTTE, M., SEGAL- CALLAHAN, M.K., CHAILLOT, D.,
BENDIRDJIAN, E. Apoptosome-inde- JACQUIN, C., CLARK, P.R., and
pendent pathway for apoptosis. MENORET, A. Differential acquisition
Biochemical analysis of APAF-1 de- of antigenic peptides by Hsp70 and
14
Julio-diciembre 2007
15
Universitas Scientiarum, Vol. 12 N° 2, 5-22
DRESSEL, R., ELSNER, L., QUENTIN, T., FUJIEDA, S., NODA, I., SAITO, H.,
WALTER, L. and GUNTHER, E. Heat HOSHINO, T., YAGITA, M. Heat shock
shock protein 70 is able to prevent heat enhances the susceptibility of tumor
shock-induced resistance of target cells cells to lysis by lymphokine-activated
to CTL. Journal of Immunology, 2000, killer cells. Archives of Otolaryngol-
164, 2362-71. ogy Head and Neck Surgery, 1995,
121, 1009-14.
DU, C., FANG, M., LI, Y., LI, L. and WANG,
X. Smac; a mitochondrial protein that GABAI, V.L., BUDAGOVA, K.R.,
promotes cytochrome c-dependent SHERMAN, M.Y. Increased expression
caspase activation by eliminating IAP of the major heat shock protein Hsp72
inhibition. Cell, 2000, 102, 33-42. in human prostate carcinoma cells is
dispensable for their viability but con-
ESCUDIER, B., DORVAL, T., CHAPUT, N., fers resistance to a variety of antican-
ANDRE, F., CABY, M.P., NOVAULT, S., cer agents. Oncogene, 2005, 24,
FLAMENT, C., LEBOULAIRE, C., 3328-38.
BORG, C., AMIGORENA, S.,
BOCCACCIO, C., BONNEROT, C., GABAI, V.L., MABUCHI, K., MOSSER,
DHELLIN, O., MOVASSAGH, M., D.D. and SHERMAN, M. Y.Hsp72 and
PIPERNO, S., ROBERT, C., SERRA, V., stress kinase c-jun N-terminal kinase
VALENTE, N., LE PECQ, J.B., SPATZ, A., regulate the bid-dependent pathway in
LANTZ, O., TURSZ, T., ANGEVIN, E., tumor necrosis factor-induced apopto-
ZITVOGEL, L. Vaccination of metastatic sis. Molecular Cell Biology, 2002, 22,
melanoma patients with autologous den- 3415-24.
dritic cell (DC) derived-exosomes: re-
sults of thefirst phase I clinical trial. GALEA-LAURI, J., RICHARDSON, A.J.,
Journal of Translational Medicine, LATCHMAN, D.S. and KATZ, D.R. In-
2005, 3, 10. creased heat shock protein 90 (hsp90)
expression leads to increased apopto-
ESKES, R., ANTONSSON, B., OSEN-SAND, sis in the monoblastoid cell line U937
A., MONTESSUIT, S., RICHTER, C., following induction with TNFalpha and
SADOUL, R., MAZZEI, G., NICHOLS, cycloheximide; a possible role in im-
A. and MARTINOU, J.C. Baxinduced munopathology. Journal of Immunol-
cytochrome c release from mitochon- ogy, 1996, 157, 4109-18.
dria is independent of the permeabil-
ity transition pore but highly GASTPAR, R., GEHRMANN, M.,
dependent on Mg2+ ions. Journal of BAUSERO, M.A., ASEA, A., GROSS,
Cell Biology, 1998, 143, 217-24. C., SCHROEDER, J.A., MULTHOFF, G.
Heat shock protein 70 surface-positive
tumor exosomes stimulate migratory
FIORENTINO, S., CHOPIN, M., DASTOT,
and cytolytic activity of natural killer
H., BOISSEL, N., REBOUL, M.,
cells. Cancer Research, 2005, 65(12),
LEGRES, L., JANIN, A., APLAN, P.,
5238-47.
SIGAUX, F., REGNAULT, A. Disruption
of T cell regulatory pathways is neces- GIBBONS, N.B., WATSON, R.W., COFFEY,
sary for immunotherapeutic cure of T R.N., BRADY, H.P., FITZPATRICK,
cell acute lymphoblastic leukemia in J.M. Heat-shock proteins inhibit induc-
mice. European Cytokine Network, tion of prostate cancer cell apoptosis.
2005, 16, 300-8. Prostate, 2000, 45, 58-65.
16
Julio-diciembre 2007
GREEN, D.R. and REED, J.C. Mitochon- JAATTELA, M., WISSING, D., BAUER, P.A.
dria and apoptosis. Science, 1998, 281, and LI, G.C. Major heat shock protein
1309-12. hsp70 protects tumor cells from tumor
necrosis factor cytotoxicity. EMBO
GROSS, A., MCDONNELL, J.M. and Journal, 1992, 11, 3507-12.
KORSMEYER, S.J. BCL-2 family
members and the mitochondria in JAATTELA, M. and WISSING, D. Heat-
apoptosis. Genes Development, 1999, shock proteins protect cells from mono-
13, 1899-1911. cyte cytotoxicity; possible mechanism
of self-protection. Journal of Experi-
GROSS, C., KOELCH, W., DEMAIO, A., mental Medicine, 1993, 177, 231-36.
ARISPE, N. and MULTHOFF, G. Cell
surface-bound heat shock protein 70 JOHNSTONE, R.M., ADAM, M.,
(Hsp70) mediates perforinindependent HAMMOND, J.R., ORR, L., TURBIDE,
apoptosis by specific binding and up- C. Vesicle formation during reticulo-
take of granzyme B. Journal of Bio- cyte maturation. Association of plasma
logical Chemistry, 2003, 278, membrane activities with released
41173-81. vesicles (exosomes). Journal of Bio-
logical Chemistry, 1987, 262, 9412-
GURBUXANI, S., BRUEY, J.M., FROMEN- 20.
TIN, A., LARMONIER, N., PARCEL-
LIER, A., JAATTELA, M., MARTIN, F., KIM, S.H., LECHMAN, E.R., BIANCO, N.,
SOLARY, E., GARRIDO, C. Selective MENON, R., KERAVALA, A., NASH,
depletion of inducible HSP70 en- J., MI, Z., WATKINS, S.C., GAM-
hances immunogenicity of rat colon BOTTO, A., ROBBINS, P.D. Exosomes
cancer cells. Oncogene, 2001, 20, derived from IL-10-treated dendritic
7478-85. cells can suppress inflammation and
collagen-induced arthritis. Journal of
HSU, H., HUANG, J., SHU, H.B., Immunology, 2005, 174, 6440-8.
BAICHWAL, V. and GOEDDEL, D.V.
TNF-dependent recruitment of the pro- KLUCK, R.M., BOSSY-WETZEL, E.,
tein kinase RIP to the TNF receptor 1 GREEN, D.R. and NEWMEYER, D.D.
signaling complex. Immunity, 1996a, The release of cytochrome c from mi-
4, 387-96. tochondria; a primary site for Bcl-2
regulation of apoptosis. Science, 1997,
HSU, H., SHU, H.B., PAN, M.G. and 275, 1132-1326.
GOEDDEL, D.V. TRADDTRAF2 and
TRADD-FADD interactions define two KOKHAEI, P., CHOUDHURY, A., MAHDIAN,
distinct TNF receptor signal transduc- R., LUNDIN, J., MOSHFEGH, A.,
tion pathways. Cell, 1996b, 84, 299- OSTERBORG, A., MELLSTEDT, H.
308. Apoptotic tumor cells are superior to tu-
17
Universitas Scientiarum, Vol. 12 N° 2, 5-22
mor cell lysate; and tumor cell RNA in GRIZZLE, W.E., ZHANG, H.G. Murine
induction of autologous T cell response mammary carcinoma exosomes pro-
in B-CLL. Leukemia, 2004, 18, 1810-5. mote tumor growth by suppression of
NK cell function. Journal of Immunol-
KOVALCHIN, J.T., WANG. R., WAGH, MS., ogy, 2006, 176, 1375-85.
AZOULAY, J., SANDERS, M., CHAN-
DAWARKAR, R.Y. In vivo delivery of LIU, Q.L., KISHI, H., OHTSUKA, K. and
heat shock protein 70 accelerates MURAGUCHI, A. Heat shock protein
wound healing by up-regulating mac- 70 binds caspase-activated DNase and
rophage-mediated phagocytosis. enhances its activity in TCRstimulated
Wound Repair & Regeneration, 2006, T cells. Blood, 2003, 102, 1788-96.
14, 129-37.
LI, H., ZHU, H., XU, C.J. and YUAN, J. LUO, X., BUDIHARDJO, I., ZOU, H.,
Cleavage of BID by caspase 8 medi- SLAUGHTER, C. and WANG, X. Bid;
ates the mitochondrial damage in the a Bcl2 interacting protein; mediates
Fas pathway of apoptosis. Cell, 1998, cytochrome c release from mitochon-
94, 491-501. dria in response to activation of cell
surface death receptors. Cell, 1998, 94,
LI, C.Y., LEE, J.S., KO, Y.G., KIM, J.I. and 481-90.
SEO, J.S. Hsp70 inhibits apoptosis
downstream of cytochrome c release MEHLEN, P., MEHLEN, A., GUILLET, D.,
and upstream of caspase-3 activation. PREVILLE, X. and ARRIGO, A.P. Tu-
Journal of Biological Chemistry, 2000, mor necrosis factor- induces changes
275, 25665-71. in the phosphorylation; cellularlocal-
ization; and oligomerization of human
LI, L., LUO, X. and WANG, X. Endonu-
hsp27; a stress protein that confers cel-
clease G is an apoptotic Dnase when
lular resistance to this cytokine. Jour-
released from mitochondria. Nature,
nal of Cell Biochemistry, 1995a, 58,
2001, 412, 95-9.
248-59.
LIOSSIS, S.N., DING, X.Z., KIANG, J.G. and
TSOKOS, G.C. Overexpression of the MEHLEN, P., PREVILLE, X., CHAREY-
heat shock protein 70 enhances the RON, P., BRIOLAY, J., KLEMENZ, R.
TCR/CD3- and Fas/Apo-1/CD95-me- ANDARRIGO, A.P. Constitutive ex-
diated apoptotic cell death in Jurkat T pression of human hsp27; drosophila
cells. Journal of Immunology, 1997, hsp27; or human ?-crystallin confers
56, 68-75. resistance to TNF-a and oxidative
stress-induced cytotoxicity in stably
LIU, C., YU, S., ZINN, K., WANG, J., transfected murine L929 fibroblasts.
ZHANG, L., JIA, Y., KAPPES, J.C., Journal of Immunology, 1995b, 154,
BARNES, S., KIMBERLY, R.P., 363-74.
18
Julio-diciembre 2007
MEHLEN, P., SCHULZE-OSTHOFF, K. and NGUYEN, D.G., BOOTH, A., GOULD, S.J.,
ARRIGO, A.P. Small stress proteins as HILDRETH, J.E. Evidence that HIV
novel regulators of apoptosis. Heat budding in primary macrophages oc-
shock protein 27 blocks Fas/APO-1- curs through the exosome release path-
and staurosporine-induced cell death. way. Journal of Biological Chemistry,
Journal of Biological Chemistry, 1996, 2003, 278, 52347-54.
271, 16510-14.
NJEMINI, R., DEMANET, C., METS, T. In-
MICHEAU, O. and TSCHOPP, J. Induction flammatory status as an important de-
of TNF receptor I-mediated apoptosis terminant of heat shock protein 70
via two sequential signaling com- serum concentrations during aging.
plexes. Cell, 2003, 114, 148-50. Biogerontology, 2004, 5, 31-8.
MIYAZAKI, T., KATO, H., KIMURA, H., NJEMINI, R., LAMBERT, M., DEMANET,
INOSE, T., FARIED, A., SOHDA, M., C., METS, T. Elevated serum heat-
NAKAJIMA, M., FUKAI, Y., MASUDA, shock protein 70 levels in patients
N., MANDA, R., FUKUCHI, M., with acute infection: use of an opti-
TSUKADA, K., KUWANO, H. Evalua- mized enzyme-linked immunosorbent
tion of tumor malignancy in esoph- assay. Scandinavian Journal of Immu-
ageal squamous cell carcinoma using nology, 2003, 58, 664-9.
different characteristic factors. Anti-
cancer Research, 2005, 25, 4005-11. OZOREN, N. and EL-DEIRY, W. Heat shock
protects HCT116 and H460 cells from
MORSE, M.A., GARST, J., OSADA, T., TRAIL-induced apoptosis. Experimen-
KHAN, S., HOBEIKA, A., CLAY, TM., tal Cell Research, 2003, 281, 175-81.
VALENTE, N., SHREENIWAS, R.,
SUTTON, M.A., DELCAYRE, A., HSU, PARCELLIER, A., SCHMITT, E., GUR-
D.H., LE PECQ, J.B., LYERLY, H.K. A BUXANI, S., SEIGNEURIN-BERNY,
phase I study of dexosome immuno- D., PANCE, A., CHANTOME, A.,
therapy in patients with advanced non- PLENCHETTE, S., KHOCHBIN, S.,
small cell lung cancer. Journal of SOLARY, E., GARRIDO, C. HSP27 is a
Translational Medicine, 2005, 3, 9. ubiquitin-binding protein involved in
I-kappaBalpha proteasomal degrada-
MULTHOFF, G., BOTZLER, C., JENNEN, tion. Molecular and Cellular Biology,
L., SCHMIDT, J., ELLWART, J., 2003, 23, 5790-802.
ISSELS, R. Heat shock protein 72 on
tumor cells: a recognition structure for PARK, H.S., CHO, S.G., KIM, C.K.,
natural killer cells. Journal of Immu- HWANG, H.S., NOH, K.T., KIM, M.S.,
nology, 1997, 158, 4341-50. HUH, S.H., KIM, M.J., RYOO, K., KIM,
E.K. Heat shock protein Hsp72 is a
MULTHOFF, G., MIZZEN, L., WINCHES- negative regulator of apoptosis signal-
TER, C.C., MILNER, C.M., WENK, S., regulating kinase 1. Molecular and
EISSNER, G., KAMPINGA, H.H., Cellular Biology, 2002, 22, 7721-30.
LAUMBACHER, B., JOHNSON, J. Heat
shock protein 70 (Hsp70) stimulates PITTET, J.F., LEE, H., MORABITO, D.,
proliferation and cytolytic activity of HOWARD, M.B., WELCH, W.J.,
natural killer cells. Experimental He- MACKERSIE, R.C. Serum levels of
matology, 1999, 27(11), 1627-36. Hsp 72 measured early after trauma
19
Universitas Scientiarum, Vol. 12 N° 2, 5-22
correlate with survival. Journal of SCREATON, G. and XU, X.N. T cell life
Trauma, 2002, 52, 611-7. and TNFreceptor family members.
Current Opininion in Immunology,
QUIJANO, S.M., SAAVEDRA, C., BRAVO, 2000, 11, 277-85.
M.M., FIORENTINO, S., OROZCO, O.
Expression of heat shock proteins SKOKOS, D., BOTROS, H.G., DEMEURE,
HSP72 and HSP73 in Colombian pa- C., MORIN, J., PERONET, R.,
tients with Hodgkin lymphoma posi- BIRKENMEIER, G., BOUDALY, S.,
tive and negative for Epstein Barr virus. MECHERI, S. Mast cell-derived
Revista Médica de Chile, 2003, 131, exosomes induce phenotypic and func-
1375-81. tional maturation of dendritic cells and
elicit specific immune responses in
RAPOSO, G., NIJMAN, H.W., STOORVO- vivo. Journal of Immunology, 2003,
GEL, W., LIEJENDEKKER, R., 170, 3037-45.
HARDING, C.V., MELIEF, C.J.,
GEUZE, H.J. B lymphocytes secrete SCHMITT, C.A., FRIDMAN, J.S., YANG,
antigen-presenting vesicles. Journal of M., LEE, S., BARANOV, E.,
Experimental Medicine, 1996, 183, HOFFMAN, R.M., LOWE, S.W. A se-
1161-72. nescence program controlled by p53
and p16INK4a contributes to the out-
RODRÍGUEZ, F., HARKINS, S., SLIFKA, come of cancer therapy. Cell, 2002,
M.K., WHITTON, J.L. Immunodomi- 109, 335-46.
nance in virus-induced CD8(+) T-cell
responses is dramatically modified by SOMERSAN, S., LARSSON, M.,
DNA immunization and is regulated FONTENEAU, J.F., BASU, S.,
by gamma interferon. Journal of Vi- SRIVASTAVA, P., BHARDWAJ, N. Pri-
rology, 2002, 76, 4251-9. mary tumor tissue lysates are enriched
in heat shock proteins and induce the
ROHDE, M., DAUGAARD, M., JENSEN, maturation of human dendritic cells.
M.H., HELIN, K., NYLANDSTED, J., Journal of Immunology, 2001, 167,
JAATTELA, M. Members of the heat- 4844-52.
shock protein 70 family promote
cancer cell growth by distinct mecha- SREEDHAR, A.M., CSERMELY, P.H. Heat
nisms. Genes Development, 2005, 19, shock proteins in the regulation of the
570-82. apoptosis: New strategies in tumor
therapy A compressive review. Phar-
RUCHALSK, K., MAO, H., LI, Z., WANG, macology and therapeutics, 2004, 101,
Z., GILLERS, S., WANG, Y., MOSSER, 227-57.
D.D., GABAI, V., SCHWARTZ, J.H.,
BORKAN, S.C. Distinct hsp70 do- SRINIVASULA, S.M., AHMAD, M.,
mains mediate apoptosis-inducing fac- FERNANDES-ALNEMRI, T. and
tor release and nuclear accumulation. ALNEMRI, E.S. Autoactivation of
Journal Biological Chemistry, 2006, procaspase-9 by Apaf-1 mediated oli-
281, 7873-80. gomerization. Molecular Cell, 1998,
7, 949-57.
SALEH, A., SRINIVASULA, S.M., BALKIR,
L., ROBBINS, P.D. and ALNEMRI, E.S. SRIVASTAVA, P.K. Heat shock proteins in
Negative regulation of the apaf-1 immune response to cancer: the Fourth
apoptosome by Hsp70. Nature Cell Paradigm. Experientia, 1994, 50,
Biology, 2000, 2, 476-83. 1054-60.
20
Julio-diciembre 2007
SUZUKI, Y., IMAI, Y., NAKAYAMA, H., TODRYK, S., MELCHER, A.A., HARD-
TAKAHASHI, K., TAKIO, K. and WICK, N., LINARDAKIS, E.,
TAKAHASHI, R. A serine protease; BATEMAN, A., COLOMBO, M.P.,
HtrA2; is released from the mitochon- STOPPACCIARO, A., VILE, R.G. Heat
dria and interacts with XIAP; induc- shock protein 70 induced during tu-
ing cell death. Moecular. Cell, 2001, mor cell killing induces Th1 cytokines
8, 613-21. and targets immature dendritic cell pre-
cursors to enhance antigen uptake.
TAKAYAMA, S., KRAJEWSKI, S., Journal of Immunology, 1999, 163,
KRAJEWSKA, M., KITADA, S., 1398-408.
ZAPATA, J.M., KOCHEL, K., KNEE, D.,
SCUDIERO, D., TUDOR, G., MILLER, UDONO, H., P.K. SRIVASTAVA. Compari-
G.J., MIYASHITA, T., YAMADA, M., son of tumor-specific immunogenici-
REED, J.C. Expression and location of ties of stress-induced proteins gp96;
Hsp70/Hsc-binding anti-apoptotic pro- hsp90; and hsp70. Journal of Immu-
tein BAG-1 and its variants in normal nology, 1994, 152, 5398-403.
tissues and tumor cell lines. Cancer
Research, 1998, 58, 3116-31. VAN NIEL, G., MALLEGOL, J., BEVILAC-
QUA, C., CANDALH, C., BRUGIERE,
TAMURA, Y., TSUBOI, N., SATO, N., S., TOMASKOVIC-CROOK, E.,
KIKUCHI, K. 70 kDa heat shock cog- HEATH, J.K., CERF-BENSUSSAN, N.,
nate protein is a transformation-asso- HEYMAN, M. Intestinal epithelial
ciated antigen and a possible target for exosomes carry MHC class II/peptides
the host’s anti-tumor immunity. Jour- able to inform the immune system in
nal of Immunology, 1993, 151, 5516- mice. Gut, 2003, 52, 1690-7.
24.
VERHAGEN, A.M., EKERT, P.G., PAKUSCH;
THERY, C., REGNAULT, A., GARIN, J., M., SILKE; J., CONNOLLY; L. M., REID,
WOLFERS, J., ZITVOGEL, L., G.E., MORITZ, R.L., SIMPSON, R.J. and
RICCIARDI-CASTAGNOLI, P., VAUX, D.L. Identification of DIABLO; a
RAPOSO, G., AMIGORENA, S. Mo- mammalian protein that promotes apo-
lecular characterization of dendritic ptosis by binding to and antagonizing
cell-derived exosomes Selective accu- IAP proteins. Cell, 2000, 102, 43-53.
21
Universitas Scientiarum, Vol. 12 N° 2, 5-22
VIEIRA, H., BOYA, P., COHEN, I., HAMEL, YANG, X., KHOSRAVI-FAR, R., CHANG,
C., HAOUZI, D., DRUILLENEC, S., H.R. and BALTIMORE, D. Daxx; a
BELZACQ, A., BRENNER, C., novel fas-binding protein that activates
ROQUES, B. and KROEMER, G. Cell JNK and apoptosis. Cell, 1997b, 89,
permeable BH3-peptides overcome 1066-76.
the cytoprotective effect of Bcl-2 and
Bcl-X(L). Oncogene, 2002, 21, 1963- ZHENG, H., LI, Z. Cutting edge: cross-pre-
77. sentation of cell-associated antigens to
MHC class I molecule is regulated by
WANG, L., GUO, Y., HUANG, W.J., KE, X., a major transcription factor for heat
POYET, J.L., MANJI, G.A., MERRIAM, shock proteins. Journal of Immunol-
S., GLUCKSMANN, M.A., DISTE- ogy, 2004, 173, 5929-33.
FANO, P.S., ALNEMRI, E.S., BERTIN,
J. Card10 is a novel caspase recruit- ZITVOGEL, L., REGNAULT, A., LOZIER,
ment domain/membrane-associated A., WOLFERS, J., FLAMENT, C.,
guanylate kinase family member that TENZA, D., RICCIARDI-CASTAG-
interacts with BCL10 and activates NF- NOLI, P., RAPOSO, G., AMIGORENA,
kappa B. Journal of Biological Chem- S. Eradication of established murine
istry, 2001, 276, 21405-9. tumors using a novel cell-free vaccine:
dendritic cell-derived exosomes. Na-
WILLIS, S., DAY, C.L., HINDS, M.G., ture Medicine, 1998, 4, 594-600.
HUANG, D.C. The Bcl-2-regulated
apoptotic pathway. Journal of Cellu- ZOU, H., HENZEL, W.J., LIU, X.,
lar Science, 2003, 116, 4053-6. LUTSCHG, A. and WANG, X. Apaf-1;
a human protein homologous to C.
WOLF, B., GREEN, D.R. Suicidal tenden- elegans CED-4; participates in cyto-
cies; apoptotic cell deathby caspase chrome c-dependent activation of
family proteinases. Journal of Biologi- caspase-3. Cell, 1997, 90, 405-13.
cal Chemistry, 1999, 274, 20049-52.
ZOU, H., LI, Y., LIU, X. and WANG, X. An
WOLFERS, J., LOZIER, A., RAPOSO, G., APAF-1.cytochrome c multimeric com-
REGNAULT, A., THERY, C., plex is a functional apoptosome that
MASURIER, C., FLAMENT, C., activates procaspase-9. Journal of
POUZIEUX, S., FAURE, F., TURSZ, T., Bioogical. Chemistry, 1999, 274,
ANGEVIN, E., AMIGORENA, S., 11549-56.
ZITVOGEL, L. Tumor-derived exo-
somes are a source of shared tumor re- ZYLICZ, M., KING, F.W., WAWRZYNOW,
jection antigens for CTL cross-priming. A. Hsp70 interactions with the tumour
Nature Medicine, 2001, 7, 297-303. suppressor protein; p53; EMBO Jour-
nal, 2001, 20, 4634-8.
YANG, J., LIU, X., BHALLA, K., KIM, C.N.,
IBRADO, A.M., CAI, J., PENG, T.I.,
JONES, D.P. and WANG, X. Prevention Recibido: 02-02-2007
of apoptosis by Bcl-2; release of cyto-
chrome c from mitochondria blocked. Aprobado: 30-08-2007
Science, 1997a, 275, 1129-32.
22